New trial alert: postoperative identification of tumor cells at the lumpectomy site of patients with early breast cancer

 A new clinical trial sponsored by the Lawson Health Research Institute in London, Ontario, is presently recruiting patients to "analyze the lumpectomy fluid (seroma)...post-surgery for the presence or absence of tumor cells..."  Study eligibility criteria includes women 50 years of age or younger diagnosed with stage 1 to stage 2B invasive breast cancer, at 6 weeks or earlier post-lumpectomy. 

To read more about this trial, click here.